Immune cells in glioblastoma use fructose to evade immune response, pointing to a new treatment target. Northwestern Medicine ...

Virginia Commonwealth University (VCU) Massey Comprehensive Center has debuted a new first-in-market brachytherapy brain tumor surgery to treat glioblastoma, according to officials.

Glioblastoma, the most common malignant brain tumor, is among the deadliest cancers, with most patients facing extremely ...

Glioblastoma (GBM) remains one of the most aggressive and challenging cancers to treat. Even with today’s standard therapies: surgery, radiation, and chemotherapy, most tumors eventually return. For ...

MORRISTOWN & SUMMIT, NJ, DECEMBER 22, 2025 – Atlantic Health today announced that it is treating the first patient in the Northeast using a groundbreaking new cell therapy to treat glioblastoma (GBM), ...

Rakesh Jain, Ph.D., director of the Edwin Steele Laboratories for Tumor Biology in the Department of Radiation Oncology at Massachusetts General Hospital and Andrew Werk Professor of Radiation ...

Newly discovered drug leverages the power of Pattern Discovery Engine™ (PDE) and is an extension of 2025 study wherein Pattern developed novel ...

Electrotherapy using injectable nanoparticles delivered directly into the tumour could pave the way for new treatment options for glioblastoma, according to a new study from Lund University in Sweden.

At present, diagnosing and treating patients can be complex ...

A potential breakthrough in the fight against glioblastoma, the deadliest form of brain cancer, is emerging from UVA Cancer Center. University of Virginia scientists, with support from the National ...

Glioblastoma is the most common and aggressive brain tumor in adults. Although there is no cure, current treatments can help slow cancer growth and reduce symptoms. Patients typically undergo surgery ...